Pain Responder Analysis: Use of Area Under the Curve to Enhance Interpretation of Clinical Trial Results
- 2 September 2009
- journal article
- clinical trial
- Published by Wiley in Pain Practice
- Vol. 9 (5) , 348-353
Abstract
Interpretation of results on patient‐reported pain outcomes from clinical trials should be meaningful to patients and healthcare providers. This study applied an area‐under‐the‐curve (AUC) analysis to responder profiles in a clinical trial of pregabalin for the treatment of fibromyalgia (FM). Data were from a 14‐week, randomized, placebo‐controlled trial of pregabalin (300, 450, or 600 mg/day) for the treatment of FM in patients meeting American College of Rheumatology criteria for FM and with a baseline pain score of at least 40 mm on the 100‐mm pain visual analogue scale. Pain was evaluated in a daily diary by patients using an 11‐point numeric rating scale (0 = no pain, 10 = worst possible pain). Response profiles on pain improvement scores and their differences between pregabalin and placebo were assessed using the AUC (derived using the trapezoidal rule) from the responder curve (vertical axis, proportion of subjects; horizontal axis, minimum percent improvement in pain). The AUC can be interpreted as if all responders were improved by the same percentage equal to the AUC divided by 100. The AUCs (2,100 for placebo, and 2,944, 3,170, and 3,349 for pregabalin 300, 450, and 600 mg, respectively) can be considered as if every responder improved by 21, 29, 31, and 33.5% in the responder's respective treatment group. Pain improvement was significantly better with pregabalin (P < 0.05), with pregabalin responders improving by 8.4% (300 mg/day), 10.7% (450 mg/day), and 12.5% (600 mg/day) more than placebo responders. This novel approach demonstrates that responder profiles can provide an enhanced interpretation of pain outcomes for patient care and symptom management.Keywords
This publication has 24 references indexed in Scilit:
- Patient perspectives on the impact of fibromyalgiaPatient Education and Counseling, 2008
- Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trialsBMC Neurology, 2008
- Enriched enrolment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic reviewBritish Journal of Clinical Pharmacology, 2008
- Numbers needed to treat calculated from responder rates give a better indication of efficacy in osteoarthritis trials than mean pain scoresArthritis Research & Therapy, 2008
- Use of the Cumulative Proportion of Responders Analysis Graph to Present Pain Data Over a Range of Cut-Off Points: Making Clinical Trial Data More UnderstandableJournal of Pain and Symptom Management, 2006
- Acute pain: individual patient meta-analysis shows the impact of different ways of analysing and presenting resultsPain, 2005
- Assessing the Clinical Benefits of Erythropoietic Agents Using Area Under the Hemoglobin Change CurveThe Oncologist, 2005
- Chronic Pain as a Disease in its Own RightPain Practice, 2004
- Area under the curve: A metric for patient subjective responses in episodic diseasesQuality of Life Research, 1995
- The american college of rheumatology 1990 criteria for the classification of fibromyalgiaArthritis & Rheumatism, 1990